ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer ; volume:14 ; number:2 ; day:14 ; month:3 ; year:2012 ; pages:1-12 ; date:4.2012
Breast cancer research ; 14, Heft 2 (14.3.2012), 1-12, 4.2012
- Contributor
-
Pinhel, Isabel
Hills, Margaret
Drury, Suzanne
Salter, Janine
Sumo, Georges
A'Hern, Roger
Bliss, Judith M.
Sestak, Ivana
Cuzick, Jack
Barrett-Lee, Peter
Harris, Adrian
Dowsett, Mitch
SpringerLink (Online service)
- DOI
-
10.1186/bcr3145
- URN
-
urn:nbn:de:1111-2016032414940
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinhel, Isabel
- Hills, Margaret
- Drury, Suzanne
- Salter, Janine
- Sumo, Georges
- A'Hern, Roger
- Bliss, Judith M.
- Sestak, Ivana
- Cuzick, Jack
- Barrett-Lee, Peter
- Harris, Adrian
- Dowsett, Mitch
- SpringerLink (Online service)
Other Objects (12)
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer